Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-09

Clinical Trial Update: Study of Cingal® and Triamcinolone Hexacetonide for the Relief of Knee Osteoarthritis Pain [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of Cingal and Triamcinolone Hexacetonide for knee osteoarthritis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cingal
  • Triamcinolone hexacetonide (triamcinolone hexacetonide)

Snippet

Sponsor: Anika Therapeutics, Inc. | Conditions: Osteoarthritis, Knee | Phase 3 | Status: COMPLETED | Results posted: 2023-08-09